BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/3/2026 7:22:48 AM | Browse: 2 | Download: 0
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Assessment of metabolic biomarkers associated with hepatic steatosis in Crohn’s disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Cristina Suárez Ferrer, Marta Abadía, María Gema Crespo Sanchez, Jose Luis Rueda García, Antonio Olveira, Miriam Romero, Marta Molero-Luis, Eduardo Martin-Arranz, Maria Sanchez-Azofra, Araceli García, Clara Amiama Roig, Joaquín Poza Cordón, Laura García-Ramírez and Maria Dolores Martin-Arranz |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Luis Álvarez Grant awarded by the Instituto de Investigación Sanitaria IdiPAZ (IdiPAZ) in 2024 |
|
|
| Corresponding Author |
Cristina Suárez Ferrer, MD, PhD, Department of Gastroenterology, Hospital La Paz Institute for Health Research (IdiPAZ), La Paz University Hospital, Paseo de la Castellana 261, Madrid 28046, Spain. cristinajsuarezferrer@gmail.com |
| Key Words |
Crohn’s disease; Metabolic dysfunction-associated steatotic liver disease; Hepatic steatosis; Hepatokines; Angiopoietin-like protein 6; Fibroblast growth factor 21; Controlled attenuation parameter; Intestinal inflammation |
| Core Tip |
Active Crohn’s disease is associated with a higher prevalence of steatosis and increased angiopoietin-like protein 6 and fibroblast growth factor 21 levels, suggesting inflammation-related metabolic alterations. Controlled attenuation parameter may serve as a reliable non-invasive tool for steatosis detection in Crohn’s disease, although inflammatory activity should be considered in its interpretation. |
| Citation |
Suárez Ferrer C, Abadía M, Crespo Sanchez MG, Rueda García JL, Olveira A, Romero M, Molero-Luis M, Martin-Arranz E, Sanchez-Azofra M, García A, Amiama Roig C, Poza Cordón J, García-Ramírez L, Martin-Arranz MD. Assessment of metabolic biomarkers associated with hepatic steatosis in Crohn’s disease. World J Gastroenterol 2026; In press
|
 |
Received |
|
2026-03-31 01:51 |
 |
Peer-Review Started |
|
2026-03-31 01:54 |
 |
First Decision by Editorial Office Director |
|
2026-04-10 10:27 |
 |
Return for Revision |
|
2026-04-10 10:27 |
 |
Revised |
|
2026-04-20 08:00 |
 |
Publication Fee Transferred |
|
2026-05-11 16:16 |
 |
Second Decision by Editor |
|
2026-07-03 02:38 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-07-03 07:22 |
 |
Articles in Press |
|
2026-07-03 07:22 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.